TL;DR: Velorum Therapeutics is a Y Combinator Winter 2024 startup Breakthrough medicines unlocking the biology of heme, currently active with a team of 5.
Breakthrough medicines unlocking the biology of heme
Last verified:
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
Built by LemStudio
Yes. Velorum Therapeutics was funded by Y Combinator in the Winter 2024 batch. Breakthrough medicines unlocking the biology of heme
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
Velorum Therapeutics was part of Y Combinator's Winter 2024 batch.
Velorum Therapeutics has a team of 5 people according to Y Combinator's directory.
Velorum Therapeutics is currently listed as Active with a team of 5 in Y Combinator's directory.
Loading interactive view…